NCI Community Oncology Funding: Deadline Approaching — Cancer Research Grants 2026

NCI Community Oncology Research Program funding represents one of the most direct routes for community cancer centers to access Phase 3 trial infrastructure that would otherwise require NCI-designated Cancer Center status — the NCORP model connects patients in their local community with practice-changing trials that were previously accessible only in academic settings. Understanding how these grants work, what they fund, and how the current application cycles are structured is relevant both for investigators at community oncology sites and for patients who want to understand what trial access looks like outside of major academic centers.

NCORP Community Site vs. Research Base Funding

• NCORP Community Sites (UG1 grants): Hospitals, oncology practices, and health systems that enroll patients in NCI-approved clinical trials and cancer care delivery research studies. Community Sites receive NCI funding to support research infrastructure — a Research Coordinator, data manager, and regulatory specialist. Annual NCORP site funding: approximately $400,000–$2M depending on accrual volume. Community Sites must demonstrate access to a defined catchment area population and a history of clinical trial participation.
• NCORP Research Bases (U10 grants): Academic institutions and cooperative groups that develop and manage the clinical trial protocols offered through the NCORP network. Research Bases are responsible for protocol development, regulatory submissions, data management, and statistical analysis across the network. Funding for Research Bases is substantially larger — $10M–$50M+ per award period. Research Base competitions are infrequent and highly competitive.
• Minority/Underserved Community Sites: NCORP has a dedicated track for community sites primarily serving minority, rural, or underserved populations — with additional funding support and priority in the network's trial portfolio. NCI actively recruits minority-serving hospitals and Federally Qualified Health Centers (FQHCs) into NCORP.

What NCORP Sites Do

• Enroll patients in Phase II and Phase III cancer prevention and treatment trials from NCI-approved Research Bases
• Conduct cancer care delivery research — studies examining how cancer care is delivered, not just what treatments are used
• Participate in cancer screening and prevention studies (e.g., lung cancer screening implementation, colorectal cancer screening outreach)
• Contribute to NCI's cancer control and health equity research agenda by enrolling diverse patient populations
• Submit patient data to NCI's data repositories and contribute biospecimens to NCI's biobanking infrastructure

How to Apply for NCORP Site Funding

• Step 1 — Identify the current NCORP FOA: Search NIH Guide for the current NCORP Community Site FOA. The active announcement (RFA-CA or PAR-CA series) specifies eligibility, required documentation, and the application deadline. Contact NCI's Cancer Therapy Evaluation Program (CTEP) for current solicitation status.
• Step 2 — Assess eligibility: Your institution must have: an active Institutional Review Board (IRB), experience submitting cancer clinical trial regulatory documents, access to a defined patient population (typically at least 1,500 newly diagnosed cancer cases per year for full Community Sites), and infrastructure for research coordination.
• Step 3 — Contact an existing Research Base: Community Sites join the network through affiliation with a Research Base — not independently. Identify which Research Base operates in your geographic area and contact their NCORP program staff to explore affiliation before applying.
• Step 4 — Prepare the application: Core sections: Specific Aims (overall goals for accrual and research), Research Strategy (accrual capacity, patient population, research infrastructure, health equity commitment), Human Subjects, Budget, and Letters of support from affiliated Research Base and institutional leadership.
• Step 5 — Submit via Grants.gov/eRA Commons: NCORP applications are submitted through the standard NIH application system. Deadlines for new NCORP Community Site applications are typically in spring (for review in fall) and fall (for review in spring). Check the active FOA for the current deadline.

Other NCI Community Oncology Grants

• NCI P30 Cancer Center Support Grants: Comprehensive Cancer Center designations requiring substantial cancer research, training, and community outreach programs. Awards typically $3M–$10M+ per year for established NCI-designated centers.
• NCI R37 MERIT Award: Extended funding for highly meritorious R01s — provides 5-year funding instead of standard project periods. Awarded at review, not by separate application.
• NCI Cancer Control R01: Standard R01 mechanism for cancer control, screening, prevention, survivorship, and health equity research — follows standard R01 due dates (June 5, October 5, February 5).